Enables PDZ domain binding activity and phosphatidylinositol-3,4-bisphosphate binding activity. Predicted to be involved in positive regulation of cell-matrix adhesion. Predicted to be located in nucleus and plasma membrane. Predicted to be part of protein-containing complex. Predicted to be active in cytoplasm and membrane. Is expressed in several structures, including central nervous system; clavicle; cranium; jaw; and thymus primordium. Orthologous to human PLEKHA2 (pleckstrin homology domain containing A2). [provided by Alliance of Genome Resources, Apr 2022]